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Abstract Optical coherence tomography (OCT) is a
non-invasive imaging technique providing real-time two-
and three-dimensional images of scattering samples with
micrometer resolution. Mapping the local reflectivity,
OCT visualizes the morphology of the sample. In ad-
dition, functional properties such as birefringence, mo-
tion or the distribution of certain substances can be
detected with high spatial resolution. The main field of
application is bio-medical imaging and diagnostics. In
ophthalmology, OCT is accepted as a clinical standard
for diagnosing and monitoring treatment of a number
of retinal diseases, and OCT is becoming an important
instrument for clinical cardiology. New applications are
emerging in various medical fields, e. g. early-stage can-
cer detection, surgical guidance, and early diagnosis of
musculoskeletal diseases. OCT has also proven its value
as a tool for developmental biology. The number of com-
panies involved in manufacturing OCT systems has in-
creased substantially during the last years—especially
due to its success in opthalmology—and this techno-
logy can be expected to continue to spread into various
fields of application.
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1 Introduction
Optical coherence tomography (OCT) has developed
rapidly since the first realization in 1991 [1]. For se-
veral years, OCT has been commercially available and
accepted as a clinical standard within ophthalmology
for diagnosis of retinal diseases. Since the commerciali-
zation of the first OCT systems by Humphrey Instru-
ments (now owned by Carl Zeiss Meditec) in 1996, the
market has rapidly grown. Presently, there are more
than 20 system manufacturers and many more suppli-
ers of components and equipment [2]. Recently, the first
commercial systems for intravascular imaging in cardi-
ology have entered the market and were approved in
the US, Europe and Asia [3,4]. Emerging applications
within biology, medicine and various technical fields are
continuously explored by many research groups world-
wide. In parallel, intense efforts are aiming at techni-
cal improvements in terms of imaging speed, resolution,
image quality and functional capabilities.
Optical coherence tomography is often described as
the optical analogue to ultrasound, as it probes the sam-
ple with light instead of sound and maps the reflectivity
as a function of depth. It is capable of providing real-
time cross-sectional images (Fig. 1), resolving features
typically on the order of 10 µm, but even depth resolu-
tion down to 1 µm or less is possible [5–7]. The penetra-
tion depth into scattering samples is limited; in biologic
tissues typically to a few millimeters, which is never-
theless higher than other high-resolution optical tech-
niques, e. g. confocal microscopy [8], can achieve. OCT
is comparably inexpensive, capable of real-time ima-
ging, and, using non-ionizing near-infrared light, safe
for repeated examinations. Hence, it is a valuable com-
plement to other clinical tomography modalities like ul-
2 Sebastian Marschall et al.
Fig. 1 Cross-sectional OCT images can non-invasively re-
veal the morphology of biologic samples. Left: scan across
the fovea centralis of a human retina. Right: image of human
skin at the palmar aspect of the thumb.
trasound imaging, magnetic resonance tomography, or
X-ray computed tomography.
In the first part of the present review, we give an
introduction into the fundamental principles of OCT
imaging, its main functional extensions, and possible
additional contrast mechanisms. The following part dis-
cusses the applications of OCT, focusing on the main
fields within ophthalmology, cardiology, and dermato-
logy and providing an overview over other biomedi-
cal and scientific applications. Besides reviewing the
current state-of-the-art, we will address new develop-
ments and recent trends, e. g. the combination of OCT
with other imaging modalities. Technical applications
of OCT are not included here, but have been covered
comprehensively by Stifter et al. [9]. A detailed discus-
sion of all theoretical aspects related to OCT would be
out of scope of this article. Instead, we may refer the
reader to the review by Fercher [10] or to the books by
Brezinski [11] or Drexler and Fujimoto [12].
2 Fundamentals
Optical Coherence Tomography is an interferometric
technique that detects reflected or backscattered light
from turbid optical media. By utilizing the low time co-
herence of broadband light sources, OCT creates depth-
resolved reflectivity profiles of the sample. This section
introduces the different implementations of OCT, dis-
cusses important system parameters along with the in-
fluence of sample properties, and presents possible func-
tional extensions.
2.1 The principle behind OCT
OCT measures the depth-resolved reflectivity of scatte-
ring materials, by detecting reflected or backscattered
light. Every OCT system probes the sample with a
beam of light, and lets the reflections interfere with a
reference beam originating from the same light source.
From the resulting interference signal, one can derive
the reflectivity profile along the beam axis. This one-
dimensional depth scan is called A-scan, in analogy to
ultrasound imaging. OCT systems perform many ad-
jacent A-scans in order to create two- or three-dimen-
sional images of the sample.
A-scans can be acquired either in the time domain
(TD) or in the frequency domain (FD). TD-OCT sys-
tems (Fig. 2) were the first to be implemented [1]. These
perform the depth scan based on low coherence in-
terferometry (LCI) which had previously been applied
for examining optical fibers [13] or for one-dimensional
length measurements of human eyes in vivo [14]. By
using light with broad spectral bandwidth and thus low
coherence length, only backreflections from the sample
with a round-trip path approximately equal to the refe-
rence path can interfere with the reference beam. This
condition creates a spatial gate as wide as the coherence
length of the light that selectively interrogates the back-
reflection from a certain depth within the sample. This
coherence gate is shifted along the probing beam axis
by changing the length of the reference path. The resul-
ting light intensity at the interferometer output is then
modulated with an amplitude corresponding to the re-
flectivity profile of the sample. Adjacent structures can
be separated in a depth profile if they are further apart
than the width of the coherence gate. Thus, the lower
the temporal coherence of the probing light is, or the
broader the bandwidth, respectively, the higher is the
depth resolution.
An FD-OCT system acquires A-scans with a fixed
reference path by measuring the spectral response of the
interferometer [15]. The information is then encoded
as an interferogram in optical frequency space, a sum
of oscillations with different periods corresponding to
reflections from different depths. A Fourier transform
of this interferogram reveals the reflectivity profile of
the sample. The same relation between bandwidth and
depth resolution as in TD-OCT is also valid for FD-
OCT.
Two basic approaches exist for implementing FD-
OCT. One can illuminate the interferometer with broad-
band light and separate the spectral components with
a spectrometer at the output (Fig. 3 a) [16,17]. This
method is termed Spectral Domain-OCT (SD-OCT).
Alternatively, one can probe with different optical fre-
quencies sequentially and measure the power at the
output with a single photo detector (Fig. 3 b) [18–20].
A similar principle was applied earlier to examine op-
tical fibers [21,22]. With a tunable narrowband light
source, one performs a sweep over a broad range of op-
tical frequencies, which led to the term Swept Source-
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Fig. 2 Typically, an OCT system is based on a Michelson in-
terferometer that directs a fraction of the light to the sample
and the remaining part to a reference mirror. The backre-
flections from both arms interfere on a photo detector. In
TD-OCT, the depth scan is performed by translating the re-
ference mirror.
OCT (SS-OCT)1. Typically, a swept source is imple-
mented as an external cavity semiconductor laser with
a rapidly tunable filter for frequency selection [23–25].
A special type among these are Fourier domain mode-
locked (FDML) lasers [26], which enable ultra-high A-
scan acquisition rates [27].
In recent years, FD-OCT has become increasingly
popular for research and medical applications, due to
its significantly higher imaging speed. FD-OCT allows
for very high A-scan rates, because it requires no me-
chanical scanning of the reference path length. This ad-
vantage comes, however, at the cost of higher data pro-
cessing complexity, limited dynamic range [28], signal
decrease with the distance of objects from zero (defined
by the reference path length), and signal ambiguity for
objects above or below zero which may require addi-
tional measures for compensation [29–35]. The choice
between SD-OCT or SS-OCT depends mainly on the
operating wavelength range [36]. For wavelengths be-
low 1µm, SD-OCT is favored because silicon-based line
cameras with sufficient pixel number and high read-
out speed are readily available. Higher wavelengths re-
quire InGaAs-based cameras which are more expensive
and not yet as technologically advanced. However, high-
performance swept sources for the 1.3µm range can
1 Throughout the literature, there is no uniform termino-
logy for the OCT embodiments performing the depth scan
in the frequency domain. The terms “frequency domain-
OCT” and “spectral domain-OCT” may be interchanged, or
“Fourier domain-OCT” may be used for either one. “Swept
source-OCT” is also called “Optical frequency domain ima-
ging”, while spectrometer-based OCT was formerly referred
to as “Spectral Radar”.
Fig. 3 In FD-OCT, each depth scan is performed by sam-
pling the interference pattern in optical frequency space, ei-
ther with a spectrometer and a broadband light source (a) or
with a photo detector and a tunable narrowband light source
(b). In both cases, the reference mirror remains at a fixed
position.
be implemented from fiber-optic components developed
for telecommunication. Similar components have also
become available for the intermediate band between
1µm and 1.1µm, although in general with lower per-
formance. Intense research is thus aiming at the de-
velopment of high-speed tunable lasers with adequate
bandwidth and output power for these wavelengths [37,
38]. Considering this, none of the different OCT imple-
mentations can be pointed out as being superior. The
optimal choice is always dependent on the actual appli-
cation.
2.2 Figures of merit
In the following, we describe the figures of merit im-
portant to characterize an OCT system or to compare
OCT with other imaging techniques. The main strength
of OCT is the depth resolution or axial resolution which
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is linked to the light source spectrum. For a Gaussian
spectrum with center wavelength λc and 3 dB-band-












In a medium of refractive index n, the resolution be-
comes δz/n. With typical light sources, for instance su-
perluminescent diodes (SLD), a resolution around 5 –
10µm in tissue (n ≈ 1.4) is possible, while ultra broad-
band light sources, e. g. supercontinuum sources, enable
a resolution down to 1µm [5,6].
Most optical microscopy techniques, such as confo-
cal microscopy [8], achieve high resolution with a high
numerical aperture (NA) objective. In contrast, OCT
gains axial resolution from the coherence gate. Hence,
one uses typically a low NA objective that provides a
long depth of focus covering the entire imaging depth
range. The transverse resolution, however, is then only
moderate (several 10µm). A number of techniques have
been developed that enable imaging with a high NA to
provide high transverse resolution while maintaining a
long imaging depth range. TD-OCT allows for dynamic
focusing, i. e. during each A-scan, the sharp focus can
be shifted through the sample synchronously with the
coherence gate. In FD-OCT, several images acquired
at the same site with different focal planes can be com-
pounded, allowing to focus tightly while maintaining an
adequate overall depth of focus [39]. Both in time and
frequency domain, one can implement optical coherence
microscopy (OCM), where so-called en-face images are
acquired in a plane transverse to the probing beam [40].
OCM combines the high spatial resolution of confocal
microscopy with the depth-selective coherence gate of
OCT.
While OCT has a high depth resolution, the pene-
tration depth into typical biologic samples is usually
limited to a few millimeters. Still, OCT is not only
useful for examining the outer body surface, because
endoscope probes [41] or subcutaneous imaging nee-
dles [42] give access to hollow organs and selected sam-
pling volumes in soft tissue. Hence, OCT is a versatile
modality complementing other clinical imaging tech-
niques (Fig. 4).
The sensitivity of an OCT system is a measure how
small a fraction of the probing light is detectable as sig-
nal above the noise floor. High sensitivity is important
for deep penetration into scattering samples. It mostly
depends on detection efficiency and noise sources pre-
sent in the system. Most OCT systems achieve sensi-
tivities in the range of 90 – 100 dB.
The imaging speed is given by the A-scan acquisition
rate and therefore limited by the reference path scan-
ning velocity in TD-OCT, the camera read-out rate in
Fig. 4 OCT and OCM close the gap between high resolu-
tion optical microscopy techniques (e. g. confocal microscopy)
and techniques with long penetration depth (e. g. ultrasound
imaging).
SD-OCT, or the sweep rate of the light source in SS-
OCT. Fast image acquisition is important for sampling
large volumes—especially for in vivo imaging where sam-
ple motion cannot be avoided [43]—and it opens the
possibility to observe dynamic phenomena temporally
resolved [44,45]. Typical state-of-the-art research sys-
tems feature A-scan rates up to several hundreds of
kilohertz. The fastest high-quality imaging reported so
far was demonstrated in an SS-OCT system performing
20.8 million A-scans per second [27].
2.3 Optical properties of the sample
Apart from the hardware parameters, the performance
of OCT imaging is also influenced by sample properties.
Absorption and scattering attenuate the signal, thereby
reducing the penetration depth [46]. A mismatch of
chromatic dispersion in the sample and the reference
path leads to a degradation of axial resolution, and
should be compensated by inserting dispersive elements
into the reference arm [47] or by signal-processing [48].
In biologic tissue, the maximum imaging depth is
limited by strong scattering [49]. Scattering arises from
variations in the index of refraction between different
tissue constituents and the surrounding medium. It is
dependent on the size and shape of present scatterers,
hence the macroscopic scattering properties of diffe-
rent tissue types can vary considerably. Absorption can
mostly be avoided by an appropriate choice of the wave-
length band. Between 600 nm and 1300 nm, the absorp-
tion of water and other typical tissue constituents like
melanin or hemoglobin is low (Fig. 5) and forms an
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optical window [50]. The choice of the operating wave-
length within this window depends on the requirements
of the application. Light at 1300 nm allows for deep pe-
netration into most tissues, like skin or mucosa, be-
cause absorption in melanin and scattering decrease
with increasing wavelength [49]. Longer wavelengths,
e. g. around 1700 nm, may enable even deeper penetra-
tion for applications where water absorption has no sig-
nificant influence [51]. However, these long wavelengths
are not suited for probing the posterior eye segment
in vivo due to strong signal attenuation in the vitreous
which mainly consists of water. Hence, the 800 nm range
exhibiting very low water absorption is commonly used
for retinal imaging [52]. For deep penetration into the
subretinal layers, the 1050 nm band provides the best
trade-off between these factors [52], while at the same
time featuring minimal chromatic dispersion in water
[53].
A phenomenon observed when imaging highly scat-
tering samples, like most biologic tissues, is speckle. The
speckle pattern, appearing as a grainy fine structure in
OCT images, is caused by interference of light reflected
from many randomly distributed scatterers within the
probing volume [54]. Speckle characteristics, such as
the size and the intensity distribution can provide addi-
tional information about the underlying scatterers [55,
56]. However, the speckle texture obscures small fea-
tures in the image and is usually considered a source of
noise. Numerous speckle reduction methods have there-
fore been developed and applied to OCT [54]. Some
are based on incoherent addition of several signals from
the same location under varying conditions, e. g. an-
gular compounding [57], spatial compounding [58,59],
and frequency compounding [60]. Where compounding
is not feasible different image processing techniques can
be applied to suppress speckle, e. g. various types of
smoothing filters, deconvolution [61,62], wavelet analy-
sis [63], rotating kernel transformation [64], and aniso-
tropic diffusion [65].
2.4 Functional imaging with OCT
In addition to structural images representing the mor-
phology of the sample, one can extract functional infor-
mation from the OCT signal. Functional OCT includes
the detection of polarization properties, local flow of
liquid, chemical composition or optical and mechanical
properties of the sample. It can provide valuable infor-
mation not contained in the structural image.
Fig. 5 Absorption spectra of typical tissue constituents (wa-
ter (H2O), oxyhemoglobin (HbO2), melanin) and aortic tis-
sue (dashed curve). The wavelength band between 0.6 and
1.3µm is well suited for optical imaging, due to relatively low
overall absorption. The ranges with bright background have
been used for OCT. Printed with permission [66]
2.4.1 Polarization sensitive OCT
Polarization sensitive OCT (PS-OCT) takes advantage
of the polarization information carried by the light back-
scattered from the sample [67,68]. Tissue can change
the polarization state of the light by several mecha-
nisms: birefringence [69], diattenuation [70], or polari-
zation scrambling [71]. While early implementations of
PS-OCT measured only reflectivity and phase retarda-
tion between the polarization axes [67,68], improved
techniques developed in recent years can extract and
image more information, such as Stokes vectors of the
backscattered light [72], Mu¨ller and Jones matrix dis-
tribution [73,74], axis orientation [75], and diattenua-
tion [70]. If diattenuation is neglected—it is very low in
most biological tissues—the three most important pa-
rameters, reflectivity, retardation, and axis orientation
(Fig. 6 a–c) can be determined by a phase sensitive two-
channel method that requires only a single measure-
ment per sample location [75]. Other quantities can be
derived from the acquired data, e. g. the degree of po-
larization uniformity (Fig. 6 d) that reveals how well a
certain volume of the sample preserves the polarization
of the probing light [76].
Whereas early versions of PS-OCT were based on
the time domain A-scan technique, FD-OCT has now
become the preferred data acquisition method. The first
spectral domain systems were developed in 2002 [77],
and since 2008 also swept sources are in use [78,79]. The
implementation PS-OCT in fiber optics is challenging,
because standard optical fibers introduce birefringence
and cross-talk between the polarization axes. Neverthe-
less, since 2000, different fiber-based setups allowing for
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Fig. 6 Cross-sectional OCT image of a human retina across
the fovea centralis. In addition to providing structural re-
flectance images (a), polarization sensitive OCT can map
quantities such as the phase retardation between the polariza-
tion axes (b) or the optical axis orientation (c). The degree of
polarization uniformity (d) derived from the measured data
quantifies how well the sample volume preserves the polari-
zation. It may be used to delineate the strongly depolarizing
retinal pigment epithelium (RPE). Printed with permission
[76].
polarization sensitive imaging were designed [80–83]. In
addition to the embodiments that measure the absolute
polarization state of the light, there is a less complex
approach to determine relative birefringence in a sam-
ple [83,84]. It is very robust against artifacts introduced
by rotating catheter probes or birefringence in bent de-
livery fibers [85] which is advantageous especially for
endoscopic applications. These developments enabling
ultra-high imaging speed and flexible, alignment-free
setups make polarization sensitive imaging feasible for
clinical applications.
Fig. 7 Circular Doppler-OCT scan around the optic nerve
head in a human retina. Structural data are displayed as gray-
scale image, and the flow velocity profile in the retinal blood
vessels is overlaid in color. The inset plot shows the time-
resolved arterial blood flow velocity averaged over the vessel
area. Courtesy of Prof. R. Leitgeb, Medical University of Vi-
enna, Austria.
2.4.2 Doppler OCT
By analyzing the OCT signal, one can extract the Dopp-
ler shift of the backscattered light caused, for instance,
by blood flow in tissue (Fig. 7). The first Doppler OCT
(DOCT) systems implemented by Izatt et al. [86] and
Chen et al. [87] in 1996 acquired the velocity distribu-
tion by performing short-time Fourier transforms on a
single A-scan. This method suffers from an inevitable
trade-off between velocity sensitivity, axial resolution
and imaging speed, which renders real-time imaging
of blood flow in small capillaries impossible. A new
method introduced in 2000 by Zhao et al. derives the
velocity from the phase difference between two subse-
quent A-scans [88]. It allows for high-resolution real-
time Doppler imaging while maintaining submillimeter
per second velocity sensitivity.
DOCT with frequency domain data acquisition has
the advantage that it requires no moving parts in the
interferometer that could cause jitter as in a TD-OCT
system. Leitgeb et al. demonstrated in 2002 a spectral
domain DOCT system that allowed for high-speed ima-
ging with high phase stability and thus a large range
of detectable velocities [89]. In 2005, Vakoc et al. im-
plemented DOCT with a swept source system [90], and
Adler et al. proved in 2007 that Fourier domain mode-
locked lasers with their high phase-stability are per-
fectly suited as light source for velocity and phase mea-
surements at ultrahigh speed [91].
2.4.3 Phase sensitive OCT
By analyzing the phase of an OCT signal, one can de-
tect very small changes of the optical path length of
the reflected light, down to a few nanometers [47]. This
method enables very precise measurements of the thick-
ness profile or changes in the thickness of transparent
specimen, e. g. cell cultures or thin material samples
[92–94]. It requires a system with very high phase sta-
bility, which is normally not given, because interfero-
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meters are subject to phase fluctuations introduced by
vibrations, air currents, and thermal drift. A number
of techniques have been developed to compensate for
these influences.
Differential phase OCT systems gain contrast from
the phase difference between two signals from different
probing volumes. Various embodiments can measure
phase variations between adjacent lateral positions [95,
96], between a narrow spot and the surrounding area
[93], or between reflections from different depths within
the sample [97]. The light of both channels travels along
the same path in the interferometer, so that phase fluc-
tuations cancel out after subtraction. Typically, the sig-
nals can be separated by using orthogonal polarization
states in the two channels, which requires that the sam-
ple does not alter the polarization state of the probing
light.
Other approaches employ a standard interferometer
where an additional coherent laser beam at a different
wavelength travels the same path as the probing light.
The interference signal of this beam provides a reference
for computational phase noise cancellation [92] or for
active stabilization of the interferometer [98].
The development of FD-OCT enabled the applica-
tion of common path interferometers, where a partial
reflection in the probing beam path is used as reference
[94,99]. Typically, a cover slip in front of the sample
serves as reference mirror. These interferometers are
very simple and feature the same passive phase stability
as the polarization-based differential phase systems.
2.4.4 OCT elastography
OCT is not only capable to image structural morpho-
logy, it can also detect microscopic displacements or
motion within a sample. In conjunction with the con-
trolled application of stress (force per unit area) or
vibrations, one can thus determine the spatially re-
solved elasticity of a specimen. There are several ap-
proaches commonly referred to as OCT elastography
or optical coherence elastography (OCE). The early
work is based on tracking the local displacement in the
speckle pattern when constant stress is applied [100–
102], which reveals spatial changes in elastic modulus
of the sample. This method is computationally inten-
sive and limited to displacements small enough to keep
the two speckle patterns sufficiently correlated. As an
alternative, it has been proposed to detect the axial
shift between adjacent A-scans resulting from oscilla-
ting stress applied synchronously with the A-scan rate
[103]. Another embodiment of OCE detects the Doppler
shift arising from mechanical vibrations that are excited
in the material [104–106]. A recently developed detec-
tion scheme enables the characterization of the sample
response over a wide range of vibration frequencies up
into the kilohertz-regime [107,108].
A number of experimental studies on ex vivo spe-
cimen demonstrated the potential of OCT elastogra-
phy to quantify the elasticity of biologic tissue [100,102,
106]. However, in vivo measurements require a method
to apply uniform stress in a controlled manner, which is
challenging especially for intra-vascular measurements
[102]. First in vivo experiments have recently been con-
ducted on human skin [107,109,110].
2.4.5 Molecular contrast
A number of extensions to OCT can extract chemical
information from the sample, i. e. map the spatial dis-
tribution of certain substances. The variety is so wide,
that we can only present some prominent examples in
this place. Detailed discussions can be found in the re-
views of Yang [111] and Boppart et al. [112], respec-
tively.
Since OCT is based on broadband light sources, it
can be used to detect the absorption features of mo-
lecules that fall within the light source spectrum, as
demonstrated by Morgner et al. in 2000 [113]. How-
ever, in the near-infrared (NIR) region, constituents of
biologic tissue exhibit mostly elastic scattering rather
than absorption [49]. Probably the most interesting mo-
lecule is hemoglobin, and spectroscopic OCT (SOCT)
was suggested as a means to assess the oxygen satu-
ration level in blood [114]. However, practical difficul-
ties of SOCT limit the applications. The measured at-
tenuation spectra are not only given by absorption,
also by scattering, and the separation of both contri-
butions requires considerable effort [115,116]. Further-
more, SOCT brings an inherent trade-off between spa-
tial and spectral resolution. In a simplified approach,
the concentration of known substances can be deter-
mined by comparing the signal attenuation in different
wavelength bands [117,118].
Specific contrast for different types of tissue or the
chemical composition can also be gained by utilizing co-
herent non-linear effects in OCT [119]. Second harmonic
generation (SHG), or frequency-doubling, does not oc-
cur in uniform, isotropic media and provides therefore
specificity for anisotropic or birefringent structures, such
as collagen layers [120,121]. With coherent anti-Stokes
Raman scattering (CARS), one can identify substances
by the frequency spectra of their molecular bond vibra-
tional states [122].
Even though most OCT applications are based on
endogenous contrast mechanisms, it is also possible to
apply exogenous contrast agents to gain enhanced or
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specific contrast. NIR dyes with characteristic absorp-
tion spectra can be useful in conjunction with a spectro-
scopic OCT technique [123]. Another way of using dyes
is the pump-probe technique, which provides contrast
based on the variation in absorption when the dye mole-
cules are excited by a pump light source [124]. A num-
ber of other contrast agents have been studied which
rely on enhanced scattering to increase the OCT signal
locally. Among these are microbubbles [125], engineered
microspheres [126], and different types of plasmon-reso-
nant gold nanoparticles [127,128]. Exogenous contrast
agents may be used to increase the contrast between
blood vessel and the surrounding tissue [125], some have
an inherent selectivity to accumulate in certain types of
tissue, and many offer the possibility to be targeted to
specific markers [123], e. g. receptors that are expressed
on diseased or cancerous cells [129]. Therefore, exoge-
nous contrast can eventually become a valuable addi-
tional tool for OCT in medical diagnostics or biologic
research.
2.4.6 Measurement of bulk optical properties
In addition to providing structural information, inten-
sity-based depth profiles offer the possibility to extract
optical properties, such as the refractive index or the
coefficients of scattering and attenuation. Considerable
effort went into theoretical models to analyze the OCT
data. However, the heterogenity of biologic tissues ren-
ders the exact spatially resolved determination of op-
tical properties often unfeasibly complicated, so that
rather average values for certain sample volumes are
calculated.
In 1995, Tearney et al. presented two procedures to
measure the refractive index as an averaged bulk pro-
perty using OCT [130]. Knu¨ttel et al. expanded Tear-
ney’s focus tracking method to measure depth-resolved
changes of the refractive index [131]. Based on the model
by Thrane et al. relating the OCT signal strength to
scattering [132], Letvitz et al. extracted the scattering
coefficient and the effective anisotropy factor from OCT
A-scans [133], and Turchin et al. developed an algo-
rithm to derive the scattering coefficients of multi-layer
samples [134]. Both methods aimed for the characteri-
zation of different pathologic states in tissue samples.
These models are based on the assumption that the
absorption coefficient is very low compared to the scat-
tering coefficient, otherwise their contributions to the
signal attenuation cannot be separated, easily. However,
the total attenuation coefficient can also contain suffi-
cient information for diagnostic purposes [135–138].
3 Applications
OCT has found manifold applications in medicine, bio-
logy and also a variety of technical applications. The
main field of application is ophthalmology, where OCT
has now been accepted as a clinical standard. A similar
development is currently ongoing in cardiology, where
the first commercial intravascular OCT systems have
found approval for clinical use. The value of OCT for
diagnosing diseases or monitoring treatment in various
other fields is subject of continued research.
In this section, we present applications of OCT in
the clinical environment and give an outlook on tech-
nical developments which may improve the diagnostic
capabilities in the near future. We will cover the main
fields and provide an overview over other areas of clin-
ical research using OCT.
3.1 Ophthalmology
In ophthalmology, OCT has been used to perform direct
imaging of the ocular structure in the anterior and pos-
terior segments of human eyes in vitro and in vivo [139–
141]. OCT yields a cross-sectional image of the retina
with a resolution comparable to a histological section in
light microscopy [142] and visualizes retinal structures
inaccessible with any other techniques (Fig. 8). OCT
is non-invasive, as opposed to fluorescein angiography,
and requires no physical contact to the eye like ultra-
sound imaging which would cause considerable discom-
fort to the patient. These advantages led to the rapid
success in ophthalmology.
OCT is the clinical standard for a number of reti-
nal diseases and is increasingly being used for diagno-
sis, monitoring and treatment control of vitreoretinal
traction and macular holes [143], age related macular
degeneration [144], glaucoma [145] and diabetic retino-
pathy [146,147]. Recent reviews giving comprehensive
description of ophthalmic OCT were published by van
Velthoven et al. [148] and Drexler and Fujimoto [149].
The first commercial OCT system for ophthalmic
use was introduced to the market in 1996 (Humphrey
Instruments, later acquired by Carl Zeiss Meditec) and
in the following years the next generations of systems
were released with improved resolution, speed and soft-
ware. Nearly 10,000 systems have been sold by Carl
Zeiss Meditec until 2008 [150] and more manufacturers
have entered the market. Today OCT is used in larger
clinics but the trend is a spread into smaller clinics as
well.
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3.1.1 OCT in ophthalmic diagnostics
OCT is used within research and clinic on daily ba-
sis. Both visualization of retinal morphology and mea-
surement of retinal thickness have become important to
evaluate patients with wet age related macular degener-
ation. Without treatment, this condition leads rapidly
to a substantial loss of vision. It can be treated with
vascular endothelium growth factor inhibitors (VEGF
inhibitors), which is repeated every month until the dis-
ease is inactive [151,152]. As the treatment requires
an intravitreal injection into the eye, the number of
re-treatments should be as low as possible. The deci-
sion for retreatment is primarily based on presence of
intraretinal or subretinal fluid and the related retinal
thickness, and major hospital clinics use OCT for the
assessment.
Retinal thickening is also frequent in diabetic reti-
nopathy, both type 1 and type 2 patients, where ap-
proximately 15% develops macular edema. The edema
develops slowly and the patient might be unaware for a
long time. Treatment is necessary if the edema is large
or close to the fovea, i. e. the center of the retina which
is the spot of maximal visual acuity. OCT has become a
standard instrument for clinical studies exploring treat-
ments of edema, in particular the use of intravitreal in-
jections of steroid and VEGF inhibitors. Blood-glucose
and blood-pressure are major risk factors for progres-
sing of diabetic retinopathy and OCT has been used
to study the relation between acute changes in blood-
glucose, retinal thickness and blood-pressure [153]. The
visualization of the pattern of fluid accumulation may
be an important tool for detecting patients with more
severe stages [146,147]. Most likely, OCT will not com-
pletely replace invasive methods such as fluorescein an-
giography but may reduce their application and thus
decrease the burden of repeated eye examinations for
patients and clinics [144,154].
A third leading cause of visual impairment is glau-
coma, a disease with atrophy of the retinal nerve fibers.
The diagnosis of glaucoma in early stages is difficult
and is based on visual fields defects, i. e. the diagno-
sis is made when damage has already occurred. Recent
studies have shown that OCT can detect the thinning
of the retinal nerve fiber layer which typically precedes
the loss of visual field [145,155,156]. With continuing
improvement of resolution and speed, OCT will likely
become a valuable tool for early stage glaucoma detec-
tion. Numerous studies are currently conducted to eva-
luate the diagnostic power of new commercially avai-
lable OCT systems [157,158].
In addition to the major diseases, OCT is used in
nearly all fields of eye diseases, such as monitoring and
Fig. 8 OCT images of diseased human retinas. (a) A macu-
lar hole (MH) has developed after detachment of the vitre-
ous humour from the retina. The OCT image shows clearly
the posterior surface of the vitreous (VIT) and reveals the
presence of an operculum (OP). (b) Central serous chorio-
retinopathy has led to a large fluid accumulation anterior (A)
and a smaller one posterior (P) to the retinal pigment epi-
thelium (RPE).
follow-up for eye surgery, macular holes, vascular occlu-
sions and examination of the anterior segment of the eye
[143,159–161].
3.1.2 Developments in ophthalmic OCT
Clinical OCT applications have until now been based
on structural images. However, functional imaging of-
fers many possibilities to acquire additional informa-
tion that helps to detect diseases. Polarization sensitive
OCT enables quantitative measurements of the bire-
fringence of the retinal nerve fiber layer [162]. Detec-
ting changes caused by early stage glaucoma can im-
prove the diagnostic accuracy. PS-OCT is also useful
for a more precise delineation of different retinal layers
based on their polarization properties [71,163]. For in-
stance, the retinal pigment epithelium can be identified
by its depolarizing nature, which may prove helpful for
the detection and monitoring of diseases affecting this
layer [164]. Doppler OCT can visualize blood flow in
retinal vessels [165]. In conjunction with fast 3D ima-
ging a new technique for non-invasive angiography can
be implemented [166] that could improve diagnosis and
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monitoring of a number of diseases, such as glaucoma,
and diabetic retinopathy.
OCT is capable of tracking small changes in the re-
flectivity of retinal layers that occur in response to an
optical stimulus with high spatial and temporal resolu-
tion. Compared to other techniques like electro-retino-
graphy, OCT provides uncomplicated, non-invasive ac-
cess for studying the retinal physiology, and may open
new possibilities to investigate retinal pathologies [44,
167].
High transverse resolution in retinal imaging is dif-
ficult to achieve due to ocular aberrations. These aber-
rations can, to a certain extent, be compensated with
adaptive optics, enabling transverse resolutions of a few
micrometers and an improved signal-to-noise ratio [168,
169].
Light in the 800 nm range enables ultrahigh resolu-
tion imaging of the retina [170]. However, it can hardly
penetrate the strongly absorbing retinal pigment epi-
thelium and is therefore less feasible for deep pene-
tration into the choroid beneath the retina. Imaging
at 1300 nm suffers from strong water absorption in the
vitreous. For this special purpose, the 1050 nm band is
interesting, since it exhibits a local minimum of absorp-
tion and vanishing chromatic dispersion in water. Since
Povazˇay et al. demonstrated the potential for deep pe-
netration into the choroid in 2003 [52], a growing num-
ber of studies makes use of the 1050 nm range [171,172].
Depending on the diagnostic value of choroid images,
1050 nm OCT may become an additional standard tool
for ophthalmology.
High data acquisition speed is important for in vivo
imaging to avoid motion artifacts [43], especially since
the eye is constantly moving [45]. It is also the key to
imaging large comprehensive 3D volumes [173] or to the
time-resolved observation of dynamic processes [44,45,
167]. The recent commercialization of high speed line
cameras and swept sources will therefore be an impor-
tant factor driving the development of the next genera-
tion of OCT systems.
3.2 Cardiology
Cardiovascular diseases are the leading cause of death
worldwide, causing millions of deaths every year [174].
Therefore, early detection of vulnerable atherosclerotic
plaques, the most prevalent condition leading to myo-
cardial infarctions, is highly relevant. Characteristic for
vulnerable plaques are a thin fibrous cap (<65µm) over-
lying a lipid pool and infiltrating macrophages [175].
Previously, intravascular ultrasound imaging (IV-US)
has been used to visualize plaque lesions, but the re-
Fig. 9 Images acquired with intravascular OCT (a) and
30 MHz ultrasound (b) in comparison. Due to its higher re-
solution, OCT has a clear advantage in visualizing the struc-
tural details of the vessel walls. i: intimia with intimial hy-
perplasia, m: media, a: adventitia, f: fibrous plaque, aste-
risk: guidewire shadow. Printed with permission [176].
solution is not sufficient to make a reliable characteri-
zation [176]. Intravascular OCT (IV-OCT) can resolve
significantly smaller details (Fig. 9), and has therefore
the potential to become an important instrument for
the classification of atherosclerotic plaques [177].
Ex vivo measurements demonstrated the ability to
distinguish different tissue structures [49] and plaque
types [133,178], followed by in vivo studies aiming at
the identification of vulnerable atherosclerotic plaques
[179–181]. OCT can quantify typical characteristics such
as the fibrous cap thickness [182], presence of lipid [135],
or macrophage infiltration [183]. The degradation of or-
ganized collagen fibers can be detected with PS-OCT
[84,184], and extraction of local attenuation coefficients
enables the automated identification of different tis-
sue structures [137]. With these capabilities of high-
resolution intravascular imaging and extraction of infor-
mation about the tissue composition, OCT has become
a valuable research tool for studying cardiovascular dis-
eases [185–187] and possible treatments [188].
Whereas the classification of atherosclerotic plaques
is subject of ongoing research, the main clinical appli-
cation of IV-OCT is monitoring and follow-up of per-
cutaneous coronary interventions [189], especially the
deployment of coronary stents [190]. When a stent is
implanted, all stent struts should be well apposed to
the vessel wall (Fig. 10) and in the subsequent healing
process covered by a layer of neointimal tissue. Incom-
plete stent apposition and lack of neointimal coverage
are suspected to increase the risk of possibly fatal late
stent thrombosis [191,192]. IV-OCT is feasible for long-
term follow-up in order to reveal the outcome of stent
deployment [193], and as comparative studies show, its
superior resolution brings a strong advantage over IV-
US [189,192,194].
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Fig. 10 OCT images of a stented porcine coronary artery
in vivo. The stent struts appear as highly reflective objects
casting radial shadows. The images reveal tissue prolapses
between the struts (asterisks). Printed with permission [195].
The major challenge for in vivo IV-OCT imaging
was to overcome the opacity of blood for near-infrared
light, arising from scattering by the red blood cells.
Clearing the blood vessel for a short time span by saline
flushing was successfully demonstrated in animals [196]
and humans [176], and has now become common prac-
tice. First patient studies indicate the general safety
of this method [197,198]. Nevertheless, research con-
tinues to eliminate the risk of ischemia completely, for
instance by matching the refractive index of the blood
serum with that of the red blood cells [199] or by using
oxygen-carrying flushing liquids [200,201]. An impor-
tant step was the introduction of high-speed FD-OCT
systems, since it enabled the acquisition of large sam-
pling volumes during relatively short flushing periods
[36,195].
IV-OCT technology has matured so far that large-
scale commercialization may be expected in the next
few years. Lightlab Imaging (subsidiary of St. Jude Me-
dical) has been selling TD-OCT systems for several
years, and recently received approval of their newest
intravascular FD-OCT systems in the US, Europe and
Asia [3]. Their competitor Volcano Corporation also re-
ceived clearance for the European market and is work-
ing towards the commercial release of their IV-OCT
products [4]. Detailed reviews on the current status
of technical development and clinical applications are
available from Prati et al. [202] and Suter et al. [203].
3.3 Dermatology
Because skin is the most easily accessible part of the
human body, the potential of OCT as instrument for
dermatology was investigated from the onset. OCT ap-
peared promising for examining skin abnormalities, espe-
cially those that are difficult to assess by visual in-
Fig. 11 OCT images of normal skin (a) and basal cell car-
cinoma (b) show a clear structural difference. The basaloid
carcinoma cell islands, main features in the corresponding his-
tological image (c), can also be recognized in the OCT image
(arrows).
spection. Hence, most research on OCT in the area of
dermatology has addressed non-melanoma skin cancer
(NMSC), although OCT has also been studied in rela-
tion to photo-damage, burns and inflammatory diseases
like psoriasis and eczema [204,205]. NMSC includes ke-
ratinocyte carcinomas, the most prevalent cancer type
in humans, and some more rare skin cancers. In NMSC
diagnosis, OCT can potentially reduce the number of
invasive skin biopsies, assist in finding an optimal lo-
cation for a biopsy or measure tumor thickness [206].
However, despite many promising initial results in re-
search, OCT has not yet been established in clinical
dermatology.
OCT images reveal the layered structure of the up-
per part of the skin. In normal skin (Fig. 11 a), usually
a clear boundary between stratum corneum and the
living part of the epidermis can be seen, and the epi-
dermis can be distinguished from the dermis in OCT
images [207,208]. Because OCT is typically not capa-
ble of resolving single cells, diagnosing diseases must
rely on a change in the skin morphology (Fig. 11 b),
such as a break up of tissue layers, general disordered
structure or change in amount of backscattered light
compared to normal skin [207,209]. For instance, OCT
can visualize loss of normal skin architecture in malig-
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nant melanomas, which could be used to differentiate
them from benign melanocytic nevi [210].
The differentiation between benign and malignant
lesions in a clinical setting is considerably more chal-
lenging because benign lesions often show the same
structure in OCT images as malignant ones. Further-
more, variations with age, skin type, anatomical site
etc. must be taken into account [207,211]. Many stu-
dies have, however, reported high correlation between
OCT images and histology, suggesting that OCT can
be used to recognize NMSC lesions [212–214].
In most of the cited studies, decisions were subjec-
tive, because they were based on visual inspection of
the OCT images. Therefore, the feasibility of machine
learning tools was investigated in several studies [215,
216]. Higher diagnostic accuracy compared to human
observers could be achieved in some cases, demonstra-
ting the potential as well as the need for improvement of
these methods. Better image quality, for instance with
speckle reduction [217], could help to extract the rele-
vant features with higher accuracy.
Functional OCT can provide additional information
that may be used to locate and characterize skin can-
cer. The highly organized structure of collagen fibers
in the dermis resulting in birefringence breaks down
in skin cancer lesions. Distinguishing normal skin and
basal cell carcinoma may be possible using PS-OCT, as
a pilot study by Strasswimmer et al. concluded [218].
However, in a recent study by Mogensen et al. con-
ducted on more than 100 patients with different types
of lesions, PS-OCT could not improve the diagnostic
acurracy compare to the assessment based on structural
OCT images [219].
Despite promising initial results, OCT could not yet
provide improved accuracy in dermatologic diagnostics.
Especially the limited penetration depth prevented a
significant improvement of diagnostic accuracy. Never-
theless, as technology is further developed, the evalua-
tion of the diagnostic potential is continued, not only
on scientific but also commercial basis. Michelson Diag-
nostics, manufacturer of the first OCT system for skin
imaging approved in the US and Europe [220,221], is
involved in numerous clinical trials on the assessment
of skin cancer and plans to expand these activities in
2011 [222].
3.4 Emerging medical applications
Numerous other possible applications of OCT in the
medical field have been investigated for their potential
in the clinical environment. OCT is promising in many
fields of cancer diagnosis, especially where excisional
biopsy or another invasive method is typically used but
undesirable [223]. OCT is endoscope-compatible [41]
and thus well suited to examine hollow organs like the
gastrointestinal tract [224–226], the bronchi [227] and
the urinary bladder [228]. Subcutaneous imaging nee-
dles [42,229,230] and forward imaging probes [231–233]
provide further possibilities to apply OCT for mini-
mally invasive examination. For instance, arthroscopic
OCT is a promising instrument for early diagnosis of os-
teoarthritis [180,234,233] or for the assessment of menis-
cal pathology [235].
Besides diagnosis, OCT is also useful for guiding or
monitoring surgery. One promising application lies in
the resection of metastatic lymph nodes in breast can-
cer patients. Nowadays, often significantly more lymph
nodes than necessary are removed, because assessment
is only done post-operative via histopathology. By exa-
mining the morphology and the optical properties with
OCT, the surgeon may determine beforehand which
lymph nodes are actually metastatic [138,236,237] and
can thus reduce the number of unnecessary resections.
3.5 Developmental biology
OCT was introduced to developmental biology in 1996
by Boppart et al. [238]. Nowadays, there is a large num-
ber of exciting applications, which we cannot cover in
this place. However, we will exemplarily present the
promising and fascinating OCT studies on heart devel-
opment. The heart is the first organ to form and func-
tion in vertebrates and undergoes simultaneous struc-
tural and functional maturation as it transforms in a
dynamic process from a straight tube to a four-cham-
bered heart [239]. Malformations of the heart are among
the most common birth defects, and are the leading
cause of birth defect-related deaths [240]. However, the
cause of most heart defects still remains unknown.
OCT has proven a well-suited tool for studies in
different small-animal models that provide fundamen-
tal understanding of normal and abnormal heart de-
velopment in vertebrates. Various groups demonstrated
anatomical and functional imaging of the developing
cardiovascular system for different species, such as frog
tadpoles [242,243], avian embryos (Fig. 12) [241,244],
and mouse embryos [245].
Recent studies in this field address so far poorly un-
derstood processes during the establishment of a func-
tioning cardiovascular system. OCT recordings on chick
embryos in vivo provided new insights about the deve-
loping coronary artery system [246] and the contraction
dynamics of the early embryonic heart loops [247].
Progress in OCT technology, for instance functional
imaging [248,249], high-speed data acquisition [244] or
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Fig. 12 3D OCT scan of a 56 hours old chick embryo heart.
The cutaway view reveals further internal structural details.
o: outflow limb, i: inflow limb, v: presumptive ventricle. Scale
bar: 250µm. Printed with permission [241].
advanced signal processing [250], has swiftly been adop-
ted in developmental biology. These enabled further
studies in early heart development and blood flow in
various models establishing OCT as an important ima-
ging tool for basic research.
3.6 Combination of modalities
In many occasions, it appears beneficial to combine
OCT with other imaging modalities in order to exploit
the advantages of different techniques. The possibilities
are numerous, therefore we will focus on some of the
most prominent examples.
Multi-Photon Tomography (MPT) is based on non-
linear processes, like two-photon absorption in endoge-
nous fluorophores and second harmonic generation. Pro-
viding submicrometer transverse resolution and chem-
ical specificity, MPT has shown promising results in
skin cancer diagnosis [251]. It is, however, a comparably
slow technique and thus limited to a small field of view,
and the penetration depth is limited to a few hundred
micrometers. A combined system could perform a fast
OCT scan to find a region of interest, which would sub-
sequently be examined in detail with MPT. In a recent
study, Ko¨nig et al. demonstrated with correlated OCT
and MPT images of skin cancer lesions diagnostic po-
tential of combining these modalities [252]. Already in
2006, Vinegoni et al. presented a combined MPT/OCM
system that provides overlaid morphologic and spectro-
scopic images of different samples [253].
In a similar manner, Raman spectroscopy can add
chemical specificity to the structural imaging capability
of OCT. It provides a chemical fingerprint of a sample,
that can be used to distinguish diseased tissue from
healthy [254,255], and is especially promising for di-
agnosis of early stage cancer or pre-cancer conditions
[256,257]. Patil et al. showed that data from Raman
spectroscopy can help to accurately classify skin lesions
when OCT images alone are ambiguous [258,259].
An important imaging modality in ophthalmology
is Scanning Laser Ophthalmoscopy (SLO) which gener-
ates en face projections of the eye fundus [260]. SLO and
OCT complement each other very well, as Hammer et
al. demonstrated in an integrated setup. SLO can pro-
vide high-contrast images of fine blood vessels or the
photoreceptor mosaic, while OCT resolves the retinal
layer structure with high penetration depth [172]. Al-
ready commercially available is OCT combined with
a scanning laser ophthalmoscope that supports vari-
ous modes of reflectance and fluorescence imaging [261,
262].
Photo-acoustic Tomography detects sound waves ge-
nerated by the absorption of short light pulses in tis-
sue [263]. It can with high specificity map the spa-
tial distribution of absorbing substances in the sam-
ple, for instance hemoglobin or pigments, and has a pe-
netration depth up to several centimeters. Combined
data, for instance general morphological information
from OCT and a detailed map of blood vessels, could
prove valuable for diagnosing pathologies that affect
vasculature, such as diabetic retinopathy or tumors.
First devices have successfully acquired combined ima-
ges of skin morphology and microvasculature [264,265].
4 Summary
OCT is a non-invasive optical imaging technique pro-
viding real-time two- or three-dimensional images with
micrometer resolution and millimeter penetration depth.
In a basic configuration, OCT can reveal the morpho-
logy of a sample, but functional extensions are possi-
ble, as well, which detect the influence on polarization,
Doppler shift due to flow of liquid, mechanical or opti-
cal properties, or the presence of certain substances in a
sample. Technical development aims for faster systems,
higher resolution and better image quality. OCT has
found manifold applications biomedical research and is
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used on regular basis in the clinic to asses various types
of pathologies.
OCT is established as a clinical standard in ophthal-
mology and has proven invaluable in diagnostics and
treatment control of many eye diseases. New commer-
cial systems feature frequency domain data acquisition
enabling a significant increase in imaging speed. Func-
tional, especially polarization sensitive imaging is ex-
pected to be integrated as a complementary tool for
improved accuracy in clinical diagnostics.
The next emerging field of clinical application lies
within cardiology, where the first commercial systems
have entered the market. Here as well, OCT can pro-
vide important information that is hardly accessible
with other techniques. For instance, it is applied for gui-
dance and follow-up of coronary interventions, such as
stent deployment, and may be used to assess the risk of
myocardial infarction. Intravascular OCT is therefore
expected to become a clinical standard in cardiology
within the next decade.
The value of OCT imaging in dermatology has been
investigated for many years. Numerous studies show the
potential of OCT for skin cancer diagnosis, but cur-
rent technology does not yet provide sufficient accu-
racy for clinical use. Significant improvements of reso-
lution, penetration depth or image quality are required
to make OCT feasible for clinical dermatologic applica-
tions. However, functional imaging, for instance pola-
rization sensitive OCT, or the combination with other
modalities such as Multiphoton Tomography may open
new possibilities to improve diagnostic accuracy.
Currently available clinical OCT systems provide
only structural images. However, technology to acquire
functional information has matured so far that some of
these techniques, e. g. PS-OCT, are expected to be part
of the next generation of OCT systems. The combina-
tion of OCT with other modalities is progressing in a
similar manner. Whereas some combinations of moda-
lities, e. g. OCT and Scanning Laser Ophthalmoscopy,
are already on the market, others are currently under
development, e. g. OCT and Multiphoton Tomography,
and may become available within the next years. Hence,
a variety of new instruments for clinical diagnostics and
biomedical research will become available in the near
future.
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